United States - English - NLM (National Library of Medicine)

peaceful mountain - croton tiglium seed (unii: 0hk2gzk66e) (croton tiglium seed - unii:0hk2gzk66e), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), sarsaparilla (unii: 2h1576d5wg) (sarsaparilla - unii:2h1576d5wg) - croton tiglium seed 30 [hp_x] in 1 g - may temporarily relieve stinging pain, skin lesions, itching and burning associated with herpetic eruptions and infection.** **these statements are based upon traditional homeopathic practice.  they have not been reviewed by the food and drug administration. may temporarily relieve stinging pain, skin lesions, itching and burning associated with herpetic eruptions and infection.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

wyeth pharmaceuticals llc, a subsidiary of pfizer inc. - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 40 mg in 10 ml - protonix i.v. is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of protonix i.v. as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. protonix i.v. is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. - protonix i.v. is contraindicated in patients with known hypersensitivity reactions including anaphylaxis to the formulation or any substituted benzimidazole. hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see warnings and precautions (5.2, 5.4), adverse reactions (6)] . - proton pump inhibitors (ppis), including protonix i.v., are contraindicated in patients receiving rilpivirine-containing products [see drug interactions (7)] . risk summary available data fro

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 40 mg in 10 ml - protonix i.v. is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of protonix i.v. as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. protonix i.v. is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. risk summary available data from published observational studies did not demonstrate an association of major malformations or other adverse pregnancy outcomes with pantoprazole. in animal reproduction studies, no evidence of adverse development outcomes was observed with pantoprazole. reproduction studies have been performed in rats at intravenous doses up to 20 mg/kg/day (4 times the recommended human dose) and rabbits at intravenous doses up to 15 mg/kg/day (6 times the recommended human dose) with administration of pantoprazole during organogenesis in pregnan

United States - English - NLM (National Library of Medicine)

homeolab usa inc. - croton tiglium seed (unii: 0hk2gzk66e) (croton tiglium seed - unii:0hk2gzk66e), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), podophyllum peltatum root (unii: 2s713a4vp3) (podophyllum - unii:2s713a4vp3), magnesium carbonate hydroxide (unii: yqo029v1l4) (magnesium cation - unii:t6v3lhy838) - croton tiglium seed 9 [hp_x] in 30 ml - relief of irregularity, straining, colic pain and flatulence this is a natural homeopathic remedy that relieves irregularity, straining, colic pain and flatulence.

United States - English - NLM (National Library of Medicine)

wyeth pharmaceuticals llc, a subsidiary of pfizer inc. - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 40 mg in 10 ml - protonix i.v. is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of protonix i.v. as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. protonix i.v. is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. risk summary available data from published observational studies did not demonstrate an association of major malformations or other adverse pregnancy outcomes with pantoprazole. in animal reproduction studies, no evidence of adverse development outcomes was observed with pantoprazole. reproduction studies have been performed in rats at intravenous doses up to 20 mg/kg/day (4 times the recommended human dose) and rabbits at intravenous doses up to 15 mg/kg/day (6 times the recommended human dose) with administration of pantoprazole during organogenesis in pregnan

United States - English - NLM (National Library of Medicine)

cardinal health - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - protonix i.v. for injection is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis. safety and efficacy of protonix i.v. for injection as a treatment of patients with gerd and a history of erosive esophagitis for more than 10 days have not been demonstrated. protonix i.v. for injection is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison syndrome in adults. protonix is contraindicated in patients with known hypersensitivity reactions including anaphylaxis to the formulation [see warnings and precautions (5.2)] or any substituted benzimidazole. hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, and urticaria [see adverse reactions (6) ]. teratogenic effects reproduction studies have been performed in rats at intravenous doses up to 20 mg/kg/day (4 times the recommended human dose based on

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - protonix i.v. is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of protonix i.v. as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. protonix i.v. is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. risk summary available data from published observational studies did not demonstrate an association of major malformations or other adverse pregnancy outcomes with pantoprazole. in animal reproduction studies, no evidence of adverse development outcomes was observed with pantoprazole. reproduction studies have been performed in rats at intravenous doses up to 20 mg/kg/day (4 times the recommended human dose) and rabbits at intravenous doses up to 15 mg/kg/day (6 times the recommended human dose) with administration of pantoprazole during organogenesis in pregnan

United States - English - NLM (National Library of Medicine)

wyeth pharmaceuticals llc, a subsidiary of pfizer inc. - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - protonix i.v. is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of protonix i.v. as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. protonix i.v. is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. risk summary available data from published observational studies did not demonstrate an association of major malformations or other adverse pregnancy outcomes with pantoprazole. in animal reproduction studies, no evidence of adverse development outcomes was observed with pantoprazole. reproduction studies have been performed in rats at intravenous doses up to 20 mg/kg/day (4 times the recommended human dose) and rabbits at intravenous doses up to 15 mg/kg/day (6 times the recommended human dose) with administration of pantoprazole during organogenesis in pregnan

United States - English - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - croton tiglium seed (unii: 0hk2gzk66e) (croton tiglium seed - unii:0hk2gzk66e) - dermatitis & diarrhea condition listed above or as directed by the physician

United States - English - NLM (National Library of Medicine)

boiron - croton tiglium seed (unii: 0hk2gzk66e) (croton tiglium seed - unii:0hk2gzk66e) - itching relieved by light rubbing* stop use and ask a doctor if symptoms persist for more than 3 days or worsen